Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence EDGHPGKPGRPGERG
Primary information
sequence IDSeq_1691
Peptide sequenceEDGHPGKPGRPGERG
CancerPDF_ID CancerPDF_ID10804, CancerPDF_ID10805, CancerPDF_ID10807,
PMID21805675,21805675,21805675
Protein NameCollagen alpha-2(I) chain,Collagen alpha-2(I) chain,Collagen alpha-2(I) chain
UniprotKB Entry NameCO1A2_HUMAN,CO1A2_HUMAN,CO1A2_HUMAN
FluidUrine,Urine,Urine
M/Z1561.7434,1577.7497,1593.7148
ChargeNA,NA,NA
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueMALDI-TOF,MALDI-TOF,MALDI-TOF
Peptide Identification techniqueMALDI-TOF-MS,MALDI-TOF-MS,MALDI-TOF-MS
Quantification TechniqueNA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDR1,1,1
CancerPDF_ID CancerPDF_ID10804, CancerPDF_ID10805, CancerPDF_ID10807,
p-ValueNA,NA,NA
SoftwareNA,NA,NA
Length15,15,15
Cancer TypeMuscle-invasive bladder cancer,Muscle-invasive bladder cancer,Muscle-invasive bladder cancer
DatabaseSwissProt Database,SwissProt Database,SwissProt Database
ModificationOxidation: 11,"Oxidation: 5, 11","Oxidation: 5, 8, 11"
Number of Patients751 bladder cancer and 127 control,751 bladder cancer and 127 control,751 bladder cancer and 127 control
RegulationDifferentially expressed between cancer vs normal samples,Differentially expressed between cancer vs normal samples,Differentially expressed between cancer vs normal samples
ValidationMann-Whitney tests and areas under receiver-operator characteristic,Mann-Whitney tests and areas under receiver-operator characteristic,Mann-Whitney tests and areas under receiver-operator characteristic
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB
Primary information
sequence IDSeq_1692
Peptide sequenceEDGHPGKPGRpGERG
CancerPDF_ID CancerPDF_ID3451,
PMID27026199
Protein NameCollagen alpha-2(I) chain
UniprotKB Entry NameCOL1A2_HUMAN
FluidUrine
fdr1560.75
Profiling Technique"CE-MS, Micro-TOF-MS"
Peptide Identification techniqueMS-MS
Labelled/Label FreeLabel Free
CancerPDF_ID CancerPDF_ID3451,
p-Valueless than 0.05
SoftwareProteome Discoverer 1.2
Length15
Cancer TypeBladder cancer
DatabaseUniprot Human non-redundant Database
Modificationp:Hydroxy-Proline
Number of Patients451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls);
RegulationDifferentially expressed between primary UBC and normal individual
ValidationIndependent Validation
SensitivityFor testing dataset 91%
SpecificityFor testing dataset 68%
AccuracyFor testing dataset 76%
Peptide AtlasNA
IEDBNA